Vincerx Pharma, Inc. (VINC)
NASDAQ: VINC · Real-Time Price · USD
0.207
0.00 (0.15%)
At close: Dec 20, 2024, 4:00 PM
0.201
-0.006 (-2.95%)
After-hours: Dec 20, 2024, 6:52 PM EST
Vincerx Pharma Employees
Vincerx Pharma had 42 employees as of December 31, 2023. The number of employees increased by 1 or 2.44% compared to the previous year.
Employees
42
Change (1Y)
1
Growth (1Y)
2.44%
Revenue / Employee
n/a
Profits / Employee
-$643,571
Market Cap
6.95M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 42 | 1 | 2.44% |
| Dec 31, 2022 | 41 | -15 | -26.79% |
| Dec 31, 2021 | 56 | 28 | 100.00% |
| Dec 31, 2020 | 28 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cutera | 430 |
| Trinity Biotech | 380 |
| Star Equity Holdings | 171 |
| T2 Biosystems | 113 |
| Kindly MD | 65 |
| Elevai Labs | 18 |
| Quantum BioPharma | 17 |
| Alzamend Neuro | 7 |
VINC News
- 17 days ago - Vincerx Pharma to Implement Cost-Controls to Support Advancing Phase 1 Study of VIP943 - GlobeNewsWire
- 2 months ago - Penny Stock Cancer-Focused Vincerx Pharma Seeks Development Partner For 2 Early-Stage Blood Cancer Candidates - Benzinga
- 2 months ago - Vincerx Reports Positive Initial Clinical Data from Ongoing VIP943 Phase 1 Dose-Escalation Study and Provides Pipeline and Corporate Updates - GlobeNewsWire
- 4 months ago - Vincerx Pharma Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 7 months ago - Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 8 months ago - Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants - GlobeNewsWire
- 8 months ago - Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and Warrants - GlobeNewsWire
- 9 months ago - Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 - GlobeNewsWire